Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1674 (LINC01674) is a member of the lincRNA family, which are RNA transcripts longer than 200 nucleotides that do not encode proteins and do not overlap with coding genes. LincRNAs are generally localized in the nucleus, where they can regulate gene expression, but can also act in the cytoplasm as molecular sponges against microRNAs, affecting cellular signaling and pathways. While this class of RNA has emerging significance in cancer and other diseases—often by regulating cell proliferation or restricting cell death—there is currently no disease, functional, or drug-interaction annotation specific to LINC01674 in major gene or pathway databases. The research on lincRNAs points to future biomarker and therapeutic potential but is at an early stage for this specific target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1674 (LINC01674).